_id
69171f0a3c536f8df23167cd
Ticker
TKNO
Name
Alpha Teknova Inc
Exchange
NASDAQ
Address
2451 Bert Dr., Hollister, CA, United States, 95023
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.teknova.com
Description
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.
Last Close
4.89
Volume
96676
Current Price
4.71
Change
-3.6809815950920193
Last Updated
2025-12-04T14:11:16.989Z
Image
data:image/webp;base64,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
Ipo Date
2021-06-25T00:00:00.000Z
Market Cap
257475328
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9463333333333334
Sentiment Sources
3
Rating
4.2
Target Price
9
Strong Buy
3
Buy
0
Hold
2
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
10454000
Cost Of Revenue
7248000
Gross Profit
3206000
Operating Expenses
7223000
Operating Income
-4017000
Interest Expense
190000
Pretax Income
-4207000
Net Income
-4286000
Eps
-0.080086722372594
Dividends Per Share
-
Shares Outstanding
53529174
Income Tax Expense
79000
EBITDA
-2426000
Operating Margin
-38.42548306868184
Total Other Income Expense Net
-190000
Cash
3204000
Short Term Investments
18912000
Receivables
5135000
Inventories
6914000
Total Current Assets
36563000
Property Plant Equipment
57517000
Total Assets
107625000
Payables
1084000
Short Term Debt
1886000
Long Term Debt
13076000
Total Liabilities
34975000
Equity
72650000
Depreciation
1591000
Change In Working Capital
-827000
Cash From Operations
-1880000
Capital Expenditures
387000
Cash From Investing
1640000
Cash From Financing
168000
Net Change In Cash
-72000
PE
-
PB
3.469580234824501
ROE
-5.899518238128011
ROA
-3.982346109175378
FCF
-2267000
Fcf Percent
-0.21685479242395256
Piotroski FScore
1
Health Score
30
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
3
Net Net Investing Score
1
Quality Investing Score
2.5
Value Investing Score
3.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
10454000
Quarters > 0 > income Statement > cost Of Revenue
7248000
Quarters > 0 > income Statement > gross Profit
3206000
Quarters > 0 > income Statement > operating Expenses
7223000
Quarters > 0 > income Statement > operating Income
-4017000
Quarters > 0 > income Statement > interest Expense
190000
Quarters > 0 > income Statement > pretax Income
-4207000
Quarters > 0 > income Statement > net Income
-4286000
Quarters > 0 > income Statement > eps
-0.080086722372594
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
53516986
Quarters > 0 > income Statement > income Tax Expense
79000
Quarters > 0 > income Statement > EBITDA
-2426000
Quarters > 0 > income Statement > operating Margin
-38.42548306868184
Quarters > 0 > income Statement > total Other Income Expense Net
-190000
Quarters > 0 > balance Sheet > cash
3204000
Quarters > 0 > balance Sheet > short Term Investments
18912000
Quarters > 0 > balance Sheet > receivables
5135000
Quarters > 0 > balance Sheet > inventories
6914000
Quarters > 0 > balance Sheet > total Current Assets
36563000
Quarters > 0 > balance Sheet > property Plant Equipment
57517000
Quarters > 0 > balance Sheet > total Assets
107625000
Quarters > 0 > balance Sheet > payables
1084000
Quarters > 0 > balance Sheet > short Term Debt
1886000
Quarters > 0 > balance Sheet > long Term Debt
13076000
Quarters > 0 > balance Sheet > total Liabilities
34975000
Quarters > 0 > balance Sheet > equity
72650000
Quarters > 0 > cash Flow > net Income
-4286000
Quarters > 0 > cash Flow > depreciation
1591000
Quarters > 0 > cash Flow > change In Working Capital
-827000
Quarters > 0 > cash Flow > cash From Operations
-1880000
Quarters > 0 > cash Flow > capital Expenditures
387000
Quarters > 0 > cash Flow > cash From Investing
1640000
Quarters > 0 > cash Flow > cash From Financing
168000
Quarters > 0 > cash Flow > net Change In Cash
-72000
Quarters > 0 > ratios > PE
-0.080086722372594
Quarters > 0 > ratios > PB
3.469580234824501
Quarters > 0 > ratios > ROE
-5.899518238128011
Quarters > 0 > ratios > ROA
-3.982346109175378
Quarters > 0 > ratios > FCF
-2267000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.21685479242395256
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
10287000
Quarters > 1 > income Statement > cost Of Revenue
6303000
Quarters > 1 > income Statement > gross Profit
3984000
Quarters > 1 > income Statement > operating Expenses
7370000
Quarters > 1 > income Statement > operating Income
-3386000
Quarters > 1 > income Statement > interest Expense
165000
Quarters > 1 > income Statement > pretax Income
-3551000
Quarters > 1 > income Statement > net Income
-3570000
Quarters > 1 > income Statement > eps
-0.06679297336423447
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
53448736
Quarters > 1 > income Statement > income Tax Expense
19000
Quarters > 1 > income Statement > EBITDA
-1796000
Quarters > 1 > income Statement > operating Margin
-32.91533002819092
Quarters > 1 > income Statement > total Other Income Expense Net
-165000
Quarters > 1 > balance Sheet > cash
3276000
Quarters > 1 > balance Sheet > short Term Investments
20724000
Quarters > 1 > balance Sheet > receivables
5140000
Quarters > 1 > balance Sheet > inventories
7610000
Quarters > 1 > balance Sheet > total Current Assets
38057000
Quarters > 1 > balance Sheet > property Plant Equipment
58565000
Quarters > 1 > balance Sheet > total Assets
110487000
Quarters > 1 > balance Sheet > payables
1204000
Quarters > 1 > balance Sheet > short Term Debt
1886000
Quarters > 1 > balance Sheet > long Term Debt
13032000
Quarters > 1 > balance Sheet > total Liabilities
34430000
Quarters > 1 > balance Sheet > equity
76057000
Quarters > 1 > cash Flow > net Income
-3570000
Quarters > 1 > cash Flow > depreciation
1590000
Quarters > 1 > cash Flow > change In Working Capital
-1613000
Quarters > 1 > cash Flow > cash From Operations
-2101000
Quarters > 1 > cash Flow > capital Expenditures
207000
Quarters > 1 > cash Flow > cash From Investing
2028000
Quarters > 1 > cash Flow > cash From Financing
-28000
Quarters > 1 > cash Flow > net Change In Cash
-101000
Quarters > 1 > ratios > PE
-0.06679297336423447
Quarters > 1 > ratios > PB
3.309932636838161
Quarters > 1 > ratios > ROE
-4.693848035026362
Quarters > 1 > ratios > ROA
-3.2311493659887587
Quarters > 1 > ratios > FCF
-2308000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.22436084378341598
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
9795000
Quarters > 2 > income Statement > cost Of Revenue
6788000
Quarters > 2 > income Statement > gross Profit
3007000
Quarters > 2 > income Statement > operating Expenses
7971000
Quarters > 2 > income Statement > operating Income
-4964000
Quarters > 2 > income Statement > interest Expense
144000
Quarters > 2 > income Statement > pretax Income
-4623000
Quarters > 2 > income Statement > net Income
-4645000
Quarters > 2 > income Statement > eps
-0.08694995705196255
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
53421533
Quarters > 2 > income Statement > income Tax Expense
22000
Quarters > 2 > income Statement > EBITDA
-3384000
Quarters > 2 > income Statement > operating Margin
-50.67891781521185
Quarters > 2 > income Statement > total Other Income Expense Net
341000
Quarters > 2 > balance Sheet > cash
3377000
Quarters > 2 > balance Sheet > short Term Investments
22896000
Quarters > 2 > balance Sheet > receivables
5616000
Quarters > 2 > balance Sheet > inventories
6573000
Quarters > 2 > balance Sheet > total Current Assets
39733000
Quarters > 2 > balance Sheet > property Plant Equipment
60137000
Quarters > 2 > balance Sheet > total Assets
113993000
Quarters > 2 > balance Sheet > payables
1555000
Quarters > 2 > balance Sheet > short Term Debt
1850000
Quarters > 2 > balance Sheet > long Term Debt
12989000
Quarters > 2 > balance Sheet > total Liabilities
35388000
Quarters > 2 > balance Sheet > equity
78605000
Quarters > 2 > cash Flow > net Income
-4645000
Quarters > 2 > cash Flow > depreciation
1580000
Quarters > 2 > cash Flow > change In Working Capital
-1786000
Quarters > 2 > cash Flow > cash From Operations
-4103000
Quarters > 2 > cash Flow > capital Expenditures
206000
Quarters > 2 > cash Flow > cash From Investing
3824000
Quarters > 2 > cash Flow > cash From Financing
-52000
Quarters > 2 > cash Flow > net Change In Cash
-331000
Quarters > 2 > ratios > PE
-0.08694995705196255
Quarters > 2 > ratios > PB
3.201010373767572
Quarters > 2 > ratios > ROE
-5.909293301952802
Quarters > 2 > ratios > ROA
-4.074811611239286
Quarters > 2 > ratios > FCF
-4309000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.4399183256763655
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
9265000
Quarters > 3 > income Statement > cost Of Revenue
7137000
Quarters > 3 > income Statement > gross Profit
2128000
Quarters > 3 > income Statement > operating Expenses
7756000
Quarters > 3 > income Statement > operating Income
-5628000
Quarters > 3 > income Statement > interest Expense
129000
Quarters > 3 > income Statement > pretax Income
-5757000
Quarters > 3 > income Statement > net Income
-5719000
Quarters > 3 > income Statement > eps
-0.10714786418372148
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
53374839
Quarters > 3 > income Statement > income Tax Expense
-38000
Quarters > 3 > income Statement > EBITDA
-3983000
Quarters > 3 > income Statement > operating Margin
-60.74473826227739
Quarters > 3 > income Statement > total Other Income Expense Net
-129000
Quarters > 3 > balance Sheet > cash
3708000
Quarters > 3 > balance Sheet > short Term Investments
26688000
Quarters > 3 > balance Sheet > receivables
4312000
Quarters > 3 > balance Sheet > inventories
6801000
Quarters > 3 > balance Sheet > total Current Assets
42776000
Quarters > 3 > balance Sheet > property Plant Equipment
61520000
Quarters > 3 > balance Sheet > total Assets
118769000
Quarters > 3 > balance Sheet > payables
825000
Quarters > 3 > balance Sheet > short Term Debt
5845000
Quarters > 3 > balance Sheet > long Term Debt
9443000
Quarters > 3 > balance Sheet > total Liabilities
36375000
Quarters > 3 > balance Sheet > equity
82394000
Quarters > 3 > cash Flow > net Income
-5719000
Quarters > 3 > cash Flow > depreciation
1645000
Quarters > 3 > cash Flow > change In Working Capital
1995000
Quarters > 3 > cash Flow > cash From Operations
-936000
Quarters > 3 > cash Flow > capital Expenditures
567000
Quarters > 3 > cash Flow > cash From Investing
-1414000
Quarters > 3 > cash Flow > cash From Financing
-87000
Quarters > 3 > cash Flow > net Change In Cash
-2437000
Quarters > 3 > ratios > PE
-0.10714786418372148
Quarters > 3 > ratios > PB
3.0511383315532683
Quarters > 3 > ratios > ROE
-6.941039396072529
Quarters > 3 > ratios > ROA
-4.8152295632698765
Quarters > 3 > ratios > FCF
-1503000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.1622234214786832
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
37745000
Annuals > 0 > income Statement > cost Of Revenue
30514000
Annuals > 0 > income Statement > gross Profit
7231000
Annuals > 0 > income Statement > operating Expenses
33377000
Annuals > 0 > income Statement > operating Income
-26146000
Annuals > 0 > income Statement > interest Expense
687000
Annuals > 0 > income Statement > pretax Income
-26833000
Annuals > 0 > income Statement > net Income
-26745000
Annuals > 0 > income Statement > eps
-0.5721356769111647
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
46745905
Annuals > 0 > income Statement > income Tax Expense
-88000
Annuals > 0 > income Statement > EBITDA
-19568000
Annuals > 0 > income Statement > operating Margin
-69.27010200026493
Annuals > 0 > income Statement > total Other Income Expense Net
-687000
Annuals > 0 > balance Sheet > cash
3708000
Annuals > 0 > balance Sheet > short Term Investments
26688000
Annuals > 0 > balance Sheet > receivables
4312000
Annuals > 0 > balance Sheet > inventories
6801000
Annuals > 0 > balance Sheet > total Current Assets
42776000
Annuals > 0 > balance Sheet > property Plant Equipment
61520000
Annuals > 0 > balance Sheet > total Assets
118769000
Annuals > 0 > balance Sheet > payables
825000
Annuals > 0 > balance Sheet > short Term Debt
5845000
Annuals > 0 > balance Sheet > long Term Debt
9443000
Annuals > 0 > balance Sheet > total Liabilities
36375000
Annuals > 0 > balance Sheet > equity
82394000
Annuals > 0 > cash Flow > net Income
-26745000
Annuals > 0 > cash Flow > depreciation
6578000
Annuals > 0 > cash Flow > change In Working Capital
-873000
Annuals > 0 > cash Flow > cash From Operations
-12391000
Annuals > 0 > cash Flow > capital Expenditures
1125000
Annuals > 0 > cash Flow > cash From Investing
-27275000
Annuals > 0 > cash Flow > cash From Financing
14890000
Annuals > 0 > cash Flow > net Change In Cash
-24776000
Annuals > 0 > ratios > PE
-0.5721356769111647
Annuals > 0 > ratios > PB
2.7289341827074787
Annuals > 0 > ratios > ROE
-32.45988785591184
Annuals > 0 > ratios > ROA
-22.518502302789447
Annuals > 0 > ratios > FCF
-13516000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.3580871638627633
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
36684000
Annuals > 1 > income Statement > cost Of Revenue
26388000
Annuals > 1 > income Statement > gross Profit
10296000
Annuals > 1 > income Statement > operating Expenses
45859000
Annuals > 1 > income Statement > operating Income
-35563000
Annuals > 1 > income Statement > interest Expense
833000
Annuals > 1 > income Statement > pretax Income
-37078000
Annuals > 1 > income Statement > net Income
-36780000
Annuals > 1 > income Statement > eps
-1.1558768070395977
Annuals > 1 > income Statement > dividends Per Share
252000
Annuals > 1 > income Statement > shares Outstanding
31820000
Annuals > 1 > income Statement > income Tax Expense
-298000
Annuals > 1 > income Statement > EBITDA
-25539000
Annuals > 1 > income Statement > operating Margin
-96.94417184603643
Annuals > 1 > income Statement > total Other Income Expense Net
-1515000
Annuals > 1 > balance Sheet > cash
28484000
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
3948000
Annuals > 1 > balance Sheet > inventories
11594000
Annuals > 1 > balance Sheet > total Current Assets
45660000
Annuals > 1 > balance Sheet > property Plant Equipment
66836000
Annuals > 1 > balance Sheet > total Assets
128587000
Annuals > 1 > balance Sheet > payables
1493000
Annuals > 1 > balance Sheet > short Term Debt
1803000
Annuals > 1 > balance Sheet > long Term Debt
13251000
Annuals > 1 > balance Sheet > total Liabilities
38551000
Annuals > 1 > balance Sheet > equity
90036000
Annuals > 1 > cash Flow > net Income
-36780000
Annuals > 1 > cash Flow > depreciation
5660000
Annuals > 1 > cash Flow > change In Working Capital
2249000
Annuals > 1 > cash Flow > cash From Operations
-18814000
Annuals > 1 > cash Flow > capital Expenditures
7934000
Annuals > 1 > cash Flow > cash From Investing
-7737000
Annuals > 1 > cash Flow > cash From Financing
12799000
Annuals > 1 > cash Flow > net Change In Cash
-13752000
Annuals > 1 > ratios > PE
-1.1558768070395977
Annuals > 1 > ratios > PB
1.6999222533208938
Annuals > 1 > ratios > ROE
-40.85032653605224
Annuals > 1 > ratios > ROA
-28.603202501030427
Annuals > 1 > ratios > FCF
-26748000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.7291462217860648
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
41420000
Annuals > 2 > income Statement > cost Of Revenue
23944000
Annuals > 2 > income Statement > gross Profit
17476000
Annuals > 2 > income Statement > operating Expenses
67135000
Annuals > 2 > income Statement > operating Income
-49659000
Annuals > 2 > income Statement > interest Expense
213000
Annuals > 2 > income Statement > pretax Income
-49391000
Annuals > 2 > income Statement > net Income
-47468000
Annuals > 2 > income Statement > eps
-1.690215069078479
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
28084000
Annuals > 2 > income Statement > income Tax Expense
-1923000
Annuals > 2 > income Statement > EBITDA
-25693000
Annuals > 2 > income Statement > operating Margin
-119.8913568324481
Annuals > 2 > income Statement > total Other Income Expense Net
268000
Annuals > 2 > balance Sheet > cash
42236000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
4283000
Annuals > 2 > balance Sheet > inventories
12247000
Annuals > 2 > balance Sheet > total Current Assets
61140000
Annuals > 2 > balance Sheet > property Plant Equipment
71313000
Annuals > 2 > balance Sheet > total Assets
152261000
Annuals > 2 > balance Sheet > payables
2449000
Annuals > 2 > balance Sheet > short Term Debt
2223000
Annuals > 2 > balance Sheet > long Term Debt
21976000
Annuals > 2 > balance Sheet > total Liabilities
52376000
Annuals > 2 > balance Sheet > equity
99885000
Annuals > 2 > cash Flow > net Income
-47468000
Annuals > 2 > cash Flow > depreciation
3165000
Annuals > 2 > cash Flow > change In Working Capital
-7334000
Annuals > 2 > cash Flow > cash From Operations
-27400000
Annuals > 2 > cash Flow > capital Expenditures
28149000
Annuals > 2 > cash Flow > cash From Investing
-28149000
Annuals > 2 > cash Flow > cash From Financing
10267000
Annuals > 2 > cash Flow > net Change In Cash
-45282000
Annuals > 2 > ratios > PE
-1.690215069078479
Annuals > 2 > ratios > PB
1.3523956550032536
Annuals > 2 > ratios > ROE
-47.52265104870601
Annuals > 2 > ratios > ROA
-31.175415897701974
Annuals > 2 > ratios > FCF
-55549000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-1.3411154031868662
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
36893000
Annuals > 3 > income Statement > cost Of Revenue
19272000
Annuals > 3 > income Statement > gross Profit
17621000
Annuals > 3 > income Statement > operating Expenses
29629000
Annuals > 3 > income Statement > operating Income
-12008000
Annuals > 3 > income Statement > interest Expense
589000
Annuals > 3 > income Statement > pretax Income
-12637000
Annuals > 3 > income Statement > net Income
-9803000
Annuals > 3 > income Statement > eps
-0.34995694883378087
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
28012017
Annuals > 3 > income Statement > income Tax Expense
-2834000
Annuals > 3 > income Statement > EBITDA
-9125000
Annuals > 3 > income Statement > operating Margin
-32.54817987152035
Annuals > 3 > income Statement > total Other Income Expense Net
-629000
Annuals > 3 > balance Sheet > cash
87518000
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
5854000
Annuals > 3 > balance Sheet > inventories
5394000
Annuals > 3 > balance Sheet > total Current Assets
101204000
Annuals > 3 > balance Sheet > property Plant Equipment
29810000
Annuals > 3 > balance Sheet > total Assets
166511000
Annuals > 3 > balance Sheet > payables
2248000
Annuals > 3 > balance Sheet > short Term Debt
200000
Annuals > 3 > balance Sheet > long Term Debt
11870000
Annuals > 3 > balance Sheet > total Liabilities
23308000
Annuals > 3 > balance Sheet > equity
143203000
Annuals > 3 > cash Flow > net Income
-9803000
Annuals > 3 > cash Flow > depreciation
2883000
Annuals > 3 > cash Flow > change In Working Capital
-1769000
Annuals > 3 > cash Flow > cash From Operations
-9069000
Annuals > 3 > cash Flow > capital Expenditures
19877000
Annuals > 3 > cash Flow > cash From Investing
-17521000
Annuals > 3 > cash Flow > cash From Financing
110793000
Annuals > 3 > cash Flow > net Change In Cash
84203000
Annuals > 3 > ratios > PE
-0.34995694883378087
Annuals > 3 > ratios > PB
0.9408867256272563
Annuals > 3 > ratios > ROE
-6.845526979183397
Annuals > 3 > ratios > ROA
-5.8872987370203775
Annuals > 3 > ratios > FCF
-28946000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-0.7845932832786707
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.080086722372594
Valuation > metrics > PB
3.469580234824501
Valuation > final Score
45.30419765175499
Valuation > verdict
15.7% Overvalued
Profitability > metrics > ROE
-5.899518238128011
Profitability > metrics > ROA
-11.722232858354074
Profitability > metrics > Net Margin
-0.409986607996939
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.48141775636613904
Risk > metrics > Interest Coverage
-21.142105263157895
Risk > final Score
-25
Risk > verdict
High
Liquidity > metrics > Current Ratio
12.31077441077441
Liquidity > metrics > Quick Ratio
9.982828282828283
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
46.90067363161839
Prev Valuations > 1
47.98989626232428
Prev Valuations > 2
49.48861668446732
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-22
Prev Risks > 1
-78
Prev Risks > 2
-115
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:18:30.124Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-17
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.0946
Earnings History > 0 > eps Difference
0.0946
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-06
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.08
Earnings History > 1 > eps Estimate
-0.1
Earnings History > 1 > eps Difference
0.02
Earnings History > 1 > surprise Percent
20
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-08
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.07
Earnings History > 2 > eps Estimate
-0.0996
Earnings History > 2 > eps Difference
0.0296
Earnings History > 2 > surprise Percent
29.7189
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-09
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.09
Earnings History > 3 > eps Estimate
-0.11
Earnings History > 3 > eps Difference
0.02
Earnings History > 3 > surprise Percent
18.1818
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-04
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.11
Earnings History > 4 > eps Estimate
-0.12
Earnings History > 4 > eps Difference
0.01
Earnings History > 4 > surprise Percent
8.3333
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-08
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.15
Earnings History > 5 > eps Estimate
-0.11
Earnings History > 5 > eps Difference
-0.04
Earnings History > 5 > surprise Percent
-36.3636
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-13
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.13
Earnings History > 6 > eps Estimate
-0.16
Earnings History > 6 > eps Difference
0.03
Earnings History > 6 > surprise Percent
18.75
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-13
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.2
Earnings History > 7 > eps Estimate
-0.24
Earnings History > 7 > eps Difference
0.04
Earnings History > 7 > surprise Percent
16.6667
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-11
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.21
Earnings History > 8 > eps Estimate
-0.24
Earnings History > 8 > eps Difference
0.03
Earnings History > 8 > surprise Percent
12.5
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-09
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.34
Earnings History > 9 > eps Estimate
-0.29
Earnings History > 9 > eps Difference
-0.05
Earnings History > 9 > surprise Percent
-17.2414
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-10
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.18
Earnings History > 10 > eps Estimate
-0.28
Earnings History > 10 > eps Difference
0.1
Earnings History > 10 > surprise Percent
35.7143
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-10
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.31
Earnings History > 11 > eps Estimate
-0.3
Earnings History > 11 > eps Difference
-0.01
Earnings History > 11 > surprise Percent
-3.3333
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-15
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.47
Earnings History > 12 > eps Estimate
-0.34
Earnings History > 12 > eps Difference
-0.13
Earnings History > 12 > surprise Percent
-38.2353
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-09
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.8
Earnings History > 13 > eps Estimate
-0.29
Earnings History > 13 > eps Difference
-0.51
Earnings History > 13 > surprise Percent
-175.8621
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-10
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.22
Earnings History > 14 > eps Estimate
-0.25
Earnings History > 14 > eps Difference
0.03
Earnings History > 14 > surprise Percent
12
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-11
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.17
Earnings History > 15 > eps Estimate
-0.2
Earnings History > 15 > eps Difference
0.03
Earnings History > 15 > surprise Percent
15
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-15
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.11
Earnings History > 16 > eps Estimate
-0.17
Earnings History > 16 > eps Difference
0.06
Earnings History > 16 > surprise Percent
35.2941
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-10
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.12
Earnings History > 17 > eps Estimate
-0.12
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
0
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-11
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.45
Earnings History > 18 > eps Estimate
-0.15
Earnings History > 18 > eps Difference
-0.3
Earnings History > 18 > surprise Percent
-200
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-06-25
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.03
Earnings History > 19 > eps Estimate
-0.04
Earnings History > 19 > eps Difference
0.01
Earnings History > 19 > surprise Percent
25
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-31
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.3411
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.3411
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2019-12-31
Earnings History > 21 > report Date
2020-03-31
Earnings History > 21 > date
2019-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
0.08
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
0.08
Earnings History > 21 > surprise Percent
-
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShowing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$9
Analyst Picks
Strong Buy
3
Buy
0
Hold
2
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 15.82% of the total shares of Alpha Teknova Inc
1.
UBS Group AG(2.9642%)
since
2025/06/30
2.
Balyasny Asset Management LLC(1.8695%)
since
2025/06/30
3.
BlackRock Inc(1.3114%)
since
2025/06/30
4.
Vanguard Group Inc(1.2187%)
since
2025/06/30
5.
Roubaix Capital, LLC(0.8221%)
since
2025/06/30
6.
Vanguard Total Stock Mkt Idx Inv(0.6149%)
since
2025/07/31
7.
CenterBook Partners LP(0.5788%)
since
2025/06/30
8.
Geode Capital Management, LLC(0.5584%)
since
2025/06/30
9.
Goldman Sachs Group Inc(0.5139%)
since
2025/06/30
10.
iShares Russell 2000 ETF(0.4664%)
since
2025/08/31
11.
Millennium Management LLC(0.461%)
since
2025/06/30
12.
Bank of America Corp(0.4287%)
since
2025/06/30
13.
Conestoga Capital Advisors, LLC(0.3593%)
since
2025/06/30
14.
Conestoga Micro Cap Growth(0.3247%)
since
2025/06/30
15.
Vanguard Institutional Extnd Mkt Idx Tr(0.2896%)
since
2025/07/31
16.
State Street Corp(0.2618%)
since
2025/06/30
17.
Bank of New York Mellon Corp(0.2162%)
since
2025/06/30
18.
Morgan Stanley - Brokerage Accounts(0.2148%)
since
2025/06/30
19.
Fidelity Small Cap Index(0.1995%)
since
2025/06/30
20.
Northern Trust Corp(0.1861%)
since
2025/06/30
21.
Renaissance Technologies Corp(0.1838%)
since
2025/06/30
22.
Marshall Wace Asset Management Ltd(0.1682%)
since
2025/06/30
23.
iShares Russell 2000 Growth ETF(0.1641%)
since
2025/08/31
24.
Divisadero Street Capital Management, LP(0.1474%)
since
2025/06/30
25.
Bridgeway Capital Management, LLC(0.1401%)
since
2025/06/30
26.
Bridgeway Ultra-Small Company Market(0.1401%)
since
2025/06/30
27.
Fidelity Extended Market Index(0.1354%)
since
2025/07/31
28.
Two Sigma Investments LLC(0.1317%)
since
2025/06/30
29.
iShares Biotechnology ETF(0.1229%)
since
2025/08/31
30.
Vanguard Russell 2000 ETF(0.0958%)
since
2025/07/31
31.
State St Russell Sm Cap® Indx SL Cl I(0.071%)
since
2025/08/31
32.
iShares Nasdaq US Biotech ETF USD Acc(0.0633%)
since
2025/08/31
33.
Fidelity Nasdaq Composite Index(0.0588%)
since
2025/07/31
34.
Conestoga Discovery Institutional(0.0559%)
since
2025/07/31
35.
Extended Equity Market Fund K(0.0525%)
since
2025/06/30
36.
Schwab Small Cap Index(0.051%)
since
2025/07/31
37.
NT R2000 Index Fund - NL(0.0489%)
since
2025/06/30
38.
Fidelity Total Market Index(0.0458%)
since
2025/07/31
39.
iShares Micro-Cap ETF(0.045%)
since
2025/08/31
40.
NT R2000 Index Fund - DC - NL - 3(0.039%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.0946
Date
2025-09-30
EPS Actual
-0.08
EPS Estimate
-0.1
EPS Difference
0.02
Surprise Percent
20%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.